Pharmacokinetics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular Blockade in Patients During Laparoscopic Surgery

Phase 4 Completed 48 enrolled Guangzhou General Hospital of Guangzhou Military Command

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to illustrate pharmacokinetics of sugammadex in reversal of vecuronium-induced neuromuscular blockade in patients during laparoscopic surgery

Timeline

Start: 2022-04-14
Primary completion: 2025-01-01
Completion: 2026-04-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sugammadex	Other / unclassified	2 mg/kg	—

Indications

No indication recorded.